|
FDA Removes Partial Clinical Hold On Idenix's IDX184
Posted on February 03, 2012 at 18:32 PM EST
The Food and Drug Administration removed its partial clinical hold on Idenix Pharmaceuticals Inc.'s (Nasdaq: IDIX) hepatitis C treatment IDX184 but investors were concerned that competitors may develop their drugs first. The stock price tumbled $1.51 to close at $11.68. Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Markets are closed on certain holidays. Stock Market Holiday List By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. Mortgage Rates, CD Rates & Home Equity Rates provided by Banks.com Press Release Service provided by PRConnect. Fundamental data supplied by Morningstar Stock quotes supplied by Telekurs USA Postage Rates Bots go here |
| ||||||

